A detailed history of Profund Advisors LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Profund Advisors LLC holds 7,377 shares of RDY stock, worth $101,950. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,377
Previous 8,198 10.01%
Holding current value
$101,950
Previous $624,000 6.09%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$75.41 - $84.21 $61,911 - $69,136
-821 Reduced 10.01%
7,377 $586,000
Q2 2024

Aug 13, 2024

BUY
$68.26 - $76.19 $30,375 - $33,904
445 Added 5.74%
8,198 $624,000
Q1 2024

May 08, 2024

BUY
$67.36 - $77.59 $808 - $931
12 Added 0.16%
7,753 $568,000
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $497,514 - $541,095
7,741 New
7,741 $538,000
Q2 2022

Aug 01, 2022

BUY
$49.62 - $58.13 $190,838 - $223,567
3,846 New
3,846 $213,000
Q4 2019

Feb 18, 2020

SELL
$36.66 - $41.78 $401,866 - $457,992
-10,962 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$34.82 - $39.26 $41,958 - $47,308
-1,205 Reduced 9.9%
10,962 $415,000
Q2 2019

Aug 13, 2019

SELL
$36.05 - $42.76 $97,515 - $115,665
-2,705 Reduced 18.19%
12,167 $456,000
Q1 2019

May 15, 2019

BUY
$35.77 - $40.57 $116,359 - $131,974
3,253 Added 28.0%
14,872 $602,000
Q4 2018

Feb 14, 2019

SELL
$31.89 - $38.44 $158,046 - $190,508
-4,956 Reduced 29.9%
11,619 $438,000
Q3 2018

Nov 13, 2018

SELL
$29.25 - $36.73 $45,630 - $57,298
-1,560 Reduced 8.6%
16,575 $573,000
Q2 2018

Aug 13, 2018

SELL
$28.49 - $35.06 $61,111 - $75,203
-2,145 Reduced 10.58%
18,135 $584,000
Q1 2018

May 14, 2018

SELL
$31.93 - $39.54 $62,263 - $77,103
-1,950 Reduced 8.77%
20,280 $663,000
Q4 2017

Feb 14, 2018

BUY
$34.15 - $37.62 $271,902 - $299,530
7,962 Added 55.8%
22,230 $835,000
Q3 2017

Nov 13, 2017

BUY
$30.11 - $37.72 $73,347 - $91,885
2,436 Added 20.59%
14,268 $509,000
Q2 2017

Aug 11, 2017

BUY
N/A
11,832
11,832 $499,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.29B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.